Companies/BioMark Diagnostics Inc.

Company profile

BioMark Diagnostics Inc.

OTC: BMKDF · Healthcare · Medical - Diagnostics & Research

Canadian filerHQ Richmond, BCReports USD

#1026 of 1,394 Healthcare companies by revenue33rd-percentile growth

EA Score

——

FH —DQ —GM —SS 45

v0.1 · 5/100 weight · pillars only

↑ Altman-Z, 3-yr revenue growth · ↓ Piotroski F, net margin

Methodology →

Revenue TTM

$65.3k

Rev growth YoY (TTM)

-42.3%

Net income (FY)

-$1.4M

Employees

Market cap

$40.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$110.8k154.2k CAD2025

Net income-$1.4M-1.9M CAD2025

Operating income-$1.4M-1.9M CAD2025

Total assets$2.2M3.1M CAD2025

Liabilities$969.2k1.4M CAD2025

Equity$1.2M1.7M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

$197.8k

FY20

FY21

$35.0k

FY22

$116.0k

FY23

$121.0k

FY24

$110.8k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BioMark Diagnostics Inc. booked $110.8k in FY2025 revenue, contracting 8.4% year over year — slower than 67% of Healthcare companies we track, at a -1249.7% net margin.

Peers · Healthcare

Vext Science, Inc.63C Rocket Doctor AI Inc.——Myomo, Inc.54D Star Equity Holdings, Inc.60C

Key facts

CEORashid Ahmed Maula Bux

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersRichmond, BC

ExchangeOTC: BMKDF

Employees9

IPO date2015-03-23

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.